Katholisches Karl-Leisner-Klinikum gGmbH, Wilhelm-Anton-Hospital Goch
- Address
- Voßheider Straße 214, 47574 Goch, Germany
Katholisches Karl-Leisner-Klinikum gGmbH, Wilhelm-Anton-Hospital Goch
The Wilhelm-Anton-Hospital Goch is a specialized clinical research center focusing on advancing treatment strategies for gastrointestinal malignancies. The institution demonstrates expertise in precision oncology approaches, particularly in the evaluation of circulating biomarkers to guide therapeutic decisions in colorectal cancer patients.
- Adjuvant therapy optimization for early-stage colorectal cancer
- Circulating tumor DNA (ctDNA) biomarker research
- UICC stage II colon and rectal cancer management
The center's research program emphasizes the integration of liquid biopsy technologies into clinical decision-making, with particular focus on ctDNA-guided treatment strategies for patients with stage II colorectal cancer. This innovative approach aims to personalize adjuvant therapy decisions based on minimal residual disease detection, potentially improving disease-free survival outcomes while avoiding unnecessary treatment in patients at lower risk of recurrence.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Universitaetsklinikum Ulm AöR2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Katholisches Karl-Leisner-Klinikum gGmbH, Wilhelm-Anton-Hospital Goch
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Adjuvant Dynamic Marker-Adjusted Personalized Therapy: Ribociclib Plus Endocrine Therapy Versus Chemotherapy in HR+/HER2- Early Breast Cancer | WSG Westdeutsche Studiengruppe GmbH | Phase III | Not Recruiting | Jul 2019 | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acalabrutinib | 1 | Unknown | 2022-04-22 | 2022-04-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.